TNFRSF4 and type 1 diabetes mellitus: While there have been no reports on the expression of TNFRSF4 in relation to Tregs in patients with type 1 diabetes, this has been reported to be significantly increased in patients with relapsed acute myeloid leukemia compared to healthy donors [46].